Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Warner

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized TrialSamaher Ashram, Houda Bahig, Aisling Barry, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term OutcomesStephen Harrow, David A Palma, Robert Olson, et al.
Cancers of the Head & Neck|December 18, 2019
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survivalNeil Mundi, Stephenie D Prokopec, Farhad Ghasemi, et al.
Radiation Oncology (London, England)|August 16, 2020
Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trialPencilla Lang, Jessika Contreras, Noah Kalman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2024
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)Meredith E Giuliani, Edith Filion, Sergio Faria, et al.
Head & Neck|November 4, 2024
Impact of Transoral Robotic Surgery Versus Radiation on Swallowing Function in Oropharyngeal Cancer Patients: A Sub-Study From a Randomized TrialJulie A Theurer, Rosemary Martino, Nedeljko Jovanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A Palma, Robert Olson, Stephen Harrow, et al.
BMC Cancer|May 7, 2020
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trialRobert Olson, Lindsay Mathews, Mitchell Liu, et al.
Plos Pathogens|July 13, 2018
Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIVVickie A Marshall, Nazzarena Labo, Xing-Pei Hao, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized TrialSamaher Ashram, Houda Bahig, Aisling Barry, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term OutcomesStephen Harrow, David A Palma, Robert Olson, et al.
Cancers of the Head & Neck|December 18, 2019
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survivalNeil Mundi, Stephenie D Prokopec, Farhad Ghasemi, et al.
Radiation Oncology (London, England)|August 16, 2020
Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trialPencilla Lang, Jessika Contreras, Noah Kalman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2024
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)Meredith E Giuliani, Edith Filion, Sergio Faria, et al.
Head & Neck|November 4, 2024
Impact of Transoral Robotic Surgery Versus Radiation on Swallowing Function in Oropharyngeal Cancer Patients: A Sub-Study From a Randomized TrialJulie A Theurer, Rosemary Martino, Nedeljko Jovanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A Palma, Robert Olson, Stephen Harrow, et al.
BMC Cancer|May 7, 2020
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trialRobert Olson, Lindsay Mathews, Mitchell Liu, et al.
Plos Pathogens|July 13, 2018
Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIVVickie A Marshall, Nazzarena Labo, Xing-Pei Hao, et al.
Pageof 16